Facebook Linkedin Twitter
Inside Precision Medicine MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma

Multiple myeloma

Scientist holding a DNA sample with the results on a computer screen in a laboratory
Molecular Dx

MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma

Christina Jackson -
0
Micrograph of multiple myeloma neoplasm from bone marrow biopsy
News & Features

First-in-Human Multiple Myeloma Study Shows 90 Percent Response Rate

Alisa Kirkin -
0
CAR T-Cell Immunotherapy
News & Features

Antibiotics Blunt CAR T Effect in Lymphoma Treatment

Malorye Branca -
0
Acute lymphoblastic leukemia ALL-L2 blood smear under light microscopy
News & Features

Test Predicts Likelihood of Revlimid Response in Myeloma

Malorye Branca -
0
Micrograph of multiple myeloma neoplasm from bone marrow biopsy
News & Features

Fatty Acid Binding Protein Aids Multiple Myeloma Progression

Julianna LeMieux, PhD -
0
Micrograph of multiple myeloma neoplasm from bone marrow biopsy
News & Features

Earlier CAR T Therapy May Benefit Multiple Myeloma Patients

Chris Anderson -
0
Micrograph of multiple myeloma neoplasm from bone marrow biopsy
Molecular Dx

Triple Drug Combo Beats Single Therapy in Multiple Myeloma Maintenance

Malorye Branca -
0
CAR T-Cell Immunotherapy
News & Features

Therapies That Engage T Cells Most Effective Against Relapsed or Refractory Multiple Myeloma

Anjali A. Sarkar, PhD -
0
Meeting handshake
Molecular Dx

Thermo Fisher Strikes $2.6B Deal to Acquire Diagnostics Company The Binding Site

Chris Anderson -
0
California State Capital
News & Features

California Gov. Gavin Newsom Signs Law to Improve Cancer Care Equity

Chris Anderson -
0
123...5Page 2 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine